View More Recent Stories
-
Scilex Holding (SCLX) Announces the Continuing Support from Endeavor Distribution LLC in the Multi-Year Agreement for Scilex’s Commercial Products and the Satisfaction of FSF 33433 LLC $10 Million L
-
Scilex Holding (SCLX) Announces It Has Received the Drug Distributor Accreditation from the National Association of Boards of Pharmacy
-
Scilex Holding (SCLX) Announces FDA Final Approval to Precision Dosing for GLOPERBA Label
-
Scilex Holding (SCLX) Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D
-
Scilex Holding (SCLX) Files for 3.5M Share Offering by Selling Stockholders
-
Scilex's (SCLX) Semnur Pharmaceuticals to Go Public via Merger with Denali Capital Acquisition Corp. (Nasdaq: DECA)
-
Scilex Holding (SCLX) Reports Prelim June Results
-
Scilex Holding (SCLX) Reports Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102
-
Scilex (SCLX) Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA
